Pharma Solutions

Emerging roles of lipids in the modulation of cancer risk and therapy - October 4, 2017

Presented by Prof. Catherine Field and Prof. Robert Chapkin, two of the world's leading experts in the molecular mechanisms by which lipids modulate cancer risk and therapy, the webinar will explore the current state of the science for EPA and DHA as a bioactive. Together with DSM's Dr. Keri Marshall, they will discuss the evidence for the use of lipids as a part of neoadjuvant therapy for two of the most common cancers: breast and colon.

Watch Webinar